Sinphar Pharmaceutical Co.,Ltd. (TPE:1734)
Taiwan
· Delayed Price · Currency is TWD 31.85
+0.10 (0.31%)
Apr 29, 2026, 1:30 PM CST
Sinphar Pharmaceutical Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 365.75 | 304.71 | 375.17 | 224.64 | -38.14 | Upgrade
|
| Depreciation & Amortization | 241.61 | 243.47 | 230.04 | 248.7 | 247.33 | Upgrade
|
| Other Amortization | 12.72 | 13.9 | 13.49 | 18.01 | 22.04 | Upgrade
|
| Loss (Gain) From Sale of Assets | 1.05 | 2.48 | -5.13 | 0.81 | 1.5 | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.12 | -0.3 | - | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | - | 0.14 | 1.68 | 0.47 | 2.54 | Upgrade
|
| Other Operating Activities | -5.87 | -3.62 | -187.15 | -26.55 | -190.8 | Upgrade
|
| Change in Accounts Receivable | -80.44 | -17.7 | 27.29 | -73.59 | -84.1 | Upgrade
|
| Change in Inventory | -9.78 | 124.29 | -102.18 | -39.62 | -15.95 | Upgrade
|
| Change in Accounts Payable | 25.13 | -106 | -31.97 | 121.92 | 7.05 | Upgrade
|
| Change in Unearned Revenue | 5.93 | 11.77 | -10.91 | 2.92 | -4.16 | Upgrade
|
| Change in Other Net Operating Assets | 28.67 | 20.37 | -13.95 | -52.42 | 188.24 | Upgrade
|
| Operating Cash Flow | 584.66 | 593.51 | 296.37 | 425.3 | 135.54 | Upgrade
|
| Operating Cash Flow Growth | -1.49% | 100.26% | -30.31% | 213.77% | -7.41% | Upgrade
|
| Capital Expenditures | -194.71 | -240.44 | -295.51 | -141.48 | -146.18 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.05 | 0.48 | 6.3 | 0.24 | 0.53 | Upgrade
|
| Sale (Purchase) of Intangibles | -6.24 | -16.28 | -5.43 | -11.96 | -15.26 | Upgrade
|
| Investment in Securities | -29.35 | -136.62 | -2.45 | 33.76 | 0.33 | Upgrade
|
| Other Investing Activities | 5.62 | 1.77 | -37.48 | -4.8 | -45.02 | Upgrade
|
| Investing Cash Flow | -224.63 | -391.08 | -334.56 | -124.24 | -205.6 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 35 | Upgrade
|
| Long-Term Debt Issued | - | 50 | 160 | 180 | 85 | Upgrade
|
| Total Debt Issued | - | 50 | 160 | 180 | 120 | Upgrade
|
| Short-Term Debt Repaid | -182 | -30 | -47 | -140 | - | Upgrade
|
| Long-Term Debt Repaid | -211.89 | -62.36 | -81.1 | -259.07 | -138.92 | Upgrade
|
| Total Debt Repaid | -393.89 | -92.36 | -128.1 | -399.07 | -138.92 | Upgrade
|
| Net Debt Issued (Repaid) | -393.89 | -42.36 | 31.9 | -219.07 | -18.92 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 15.58 | Upgrade
|
| Common Dividends Paid | -181.14 | -167.72 | -167.72 | -33.54 | -33.54 | Upgrade
|
| Other Financing Activities | -1 | 1 | 15.15 | -10.72 | 159.83 | Upgrade
|
| Financing Cash Flow | -576.03 | -209.08 | -120.67 | -263.33 | 122.95 | Upgrade
|
| Foreign Exchange Rate Adjustments | 4.46 | 7.83 | -4.2 | 5.04 | -1.88 | Upgrade
|
| Net Cash Flow | -211.53 | 1.18 | -163.07 | 42.77 | 51.02 | Upgrade
|
| Free Cash Flow | 389.95 | 353.08 | 0.86 | 283.82 | -10.64 | Upgrade
|
| Free Cash Flow Growth | 10.45% | 40955.23% | -99.70% | - | - | Upgrade
|
| Free Cash Flow Margin | 11.57% | 11.21% | 0.03% | 9.93% | -0.44% | Upgrade
|
| Free Cash Flow Per Share | 2.04 | 1.85 | 0.01 | 1.49 | -0.06 | Upgrade
|
| Cash Interest Paid | 34.15 | 36.49 | 33.65 | 27.64 | 24.86 | Upgrade
|
| Cash Income Tax Paid | 41.91 | 5.3 | 57.37 | 47.1 | 44.35 | Upgrade
|
| Levered Free Cash Flow | 279.33 | 232.08 | -125.83 | 206.61 | 65.95 | Upgrade
|
| Unlevered Free Cash Flow | 300.48 | 255.06 | -104.76 | 223.99 | 81.45 | Upgrade
|
| Change in Working Capital | -30.49 | 32.73 | -131.73 | -40.79 | 91.08 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.